Alvarado Urbina; Gabriel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Alvarado Urbina; Gabriel.The latest application filed is for "compositions and methods for selective delivery of oligonucleotide molecules to cell types".

Company Profile

0.5.5

Alvarado Urbina; Gabriel - Nepean CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for the treatment of parkinson disease by the selective delivery of oligonucleotide molecules to specific neuron types Grant 10,125,363 - Montefeltro , et al. November 13, 2	2018-11-13
Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types Grant 10,071,163 - Montefeltro , et al. September 11, 2	2018-09-11
Compositions and Methods for Selective Delivery of Oligonucleotide Molecules to Cell Types App 20170073679 - CARMONA OROZCO; Maria del Carmen ; et al.	2017-03-16
Compositions And Methods For Selective Delivery Of Oligonucleotide Molecules To Specific Neuron Types App 20160235856 - MONTEFELTRO; Andres Pablo ; et al.	2016-08-18
Compositions and Methods for the Treatment of Parkinson Disease by the Selective Delivery of Oligonucleotide Molecules to Specific Neuron Types App 20160083726 - MONTEFELTRO; Andres Pablo ; et al.	2016-03-24
Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types Grant 9,193,969 - Montefeltro , et al. November 24, 2	2015-11-24
Compositions and methods for the treatment of parkinson disease by the selective delivery of oligonucleotide molecules to specific neuron types Grant 9,084,825 - Montefeltro , et al. July 21, 2	2015-07-21
Compositions and Methods for Selective Delivery of Oligonucleotide Molecules to Cell Types App 20140315795 - CARMONA OROZCO; Maria del Carmen ; et al.	2014-10-23
Compositions and Methods for the Treatment of Parkinson Disease by the Selective Delivery of Oligonucleotide Molecules to Specific Neuron Types App 20140120158 - MONTEFELTRO; Andres Pablo ; et al.	2014-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.